ABSTRACT
Description: Primavax was a trivalent vaccine containing diphtheria toxoid, tetanus toxoid, and recombinant hepatitis B surface antigen (rHBsAg). Each monodose preparation contained 30 IU purified adsorbed diphtheria toxoid, 40 IU tetanus toxoid, and 5 µg rHBsAg in a final volume of 0.5 ml. The product was presented in a prefilled glass syringe as a suspension for intramuscular administration.
